SARS-CoV-2 will become one of the common coronaviruses colds by the end of 2020 in the northern hemisphere.
What's happening now is not the second wave of the pandemic, but CASEDEMIC.
As everybody noticed, the COVID-19 pandemic is already over in the northern hemisphere. What is happening now is not the second wave of the pandemic but casedemic; only cases can increase while deaths or severe cases keep declining.
Retweet please to let people know what's happening all over Europe, and in many other parts of the world.
— Ivor Cummins (@FatEmperor) August 18, 2020
The #Casedemic is escalating - and societal restrictions are coming in fast based on it.
Just a few examples here - but nearly all of Europe has the same shocking story 🤨 pic.twitter.com/lacFjdyx6C
Here is a Tokyo version of casedemic. The situation has changed since the end of June; more cases (with more testing) but less deaths.
I have calculated 7-day moving average of case-fatality-ratio for Tokyo and West Europe countries and found that CFR has dropped to one-tenth to one-twentieth of the first wave in April.
Why has the CFR changed drastically? It is not because of the weakening of the virus but our T-cell memories the virus.
I don't think it's correct. The countries which had suppressed the initial wave by the early and draconian way such as Australia, Israel, Hong Kong, etc. have seen the second wave with the same high CFR.
https://www.worldometers.info/coronavirus/country/australia/
https://www.worldometers.info/coronavirus/country/israel/
https://www.worldometers.info/coronavirus/country/china-hong-kong-sar/
- Those who were very vulnerable died in the first wave
- Our T-cell memories SARS-CoV-2 and gains immunity
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Look at the above figure. Most of the people who were not infected but just exposed have gained SARS-CoV-2-specific response!
The papers below are worth reading.
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
https://www.cell.com/cell/fulltext/S0092-8674(20)31008-4
SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
The last paper reveals that all the people who were infected with SARS in 2003 (n=23) still has the SARS-specific T cell immunity after 17 years! This indicates that our SARS-CoV-2-specific T cell immunity can last for a long period.
(BCG vaccination strengthens T cell immunity.)
Don't care about antibodies. Let's care for innate immunity; T cell and macrophage.
Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults
Memory T Lymphocytes Generated by Mycobacterium bovis BCG Vaccination Reside within a CD4 CD44lo CD62 Ligandhi Population
- BCG vaccination levels up the baseline of T cell immunity
- BCG vaccination strengthens T-cell memory
A common coronavirus OC43 made its debut in 1889-1890 and killed around 625 per 1 million.
I found a very interesting history of the common coronavirus; OC43.
1889–1890 flu pandemic
When the human coronavirus OC43 made its debut in 1889-1890, it killed 1 million people, which were around 625 deaths per 1 million population at that time. This death rate is a similar range of COVID-19 death rate among the countries where BCG vaccination is not compulsory. This is a coincidence but indicates that it's a good historical reference.
The 1889-1890 pandemic had continued for a few years but I think this COVID-19 pandemic will ends sooner, maybe in a year or so, because we are living in a global economy.
Our Coronavirus Predicament Isn’t All That New
(Rushing to a new vaccine may be riskier than getting infected with SARS-CoV-2. The old BCG vaccine would work.)
I am worried about the rush to the new vaccines and think that exposing to the real virus may be at a lower risk than taking the new vaccines which cause side-effects among the healthy young samples. If it is a success, it's a novel prize invention because it means that we find a way to prevent a cold.
I believe BCG vaccination is much safer and quite effective. Please check the result from a UAE hospital.
Very strong evidence of the BCG hypothesis!!
— J Sato (@j_sato) August 12, 2020
Among 280 UAE hospital staffers, 71 staffers received booster BCG vaccination (strain unknown) in early March and 209 not.
Received BCG booster (n=71) -> C19 infected 0 (0%)
Not received BCG booster (n=209) -> C19 infected 18 (8.6%) https://t.co/CT4doC1yYD
SARS-CoV-2 will become one of the common coronaviruses colds.
SARS-CoV-2 will become one of the common coronaviruses colds by the end of 2020 in the northern hemisphere.
Comments
Post a Comment